Georgia Bio Legislative Blog

For any questions, accommodate requests, and take suggestions as they arise please contact Joseph Santoro.

~Joseph Santoro, VP of External Affairs, Georgia Bio

jsantoro@gabio.org

7.23.2020. Cornerstone Government Affairs COVID-19 Legislative Update

July 24, 2020

LegislationSupplemental IVTimeline: After a couple fire drills between the White House and Senate Republicans, Leader McConnell said on the Senate floor today that Republicans will be releasing the bill early next week. He indicated that various Senate Chairs and other senators will be introducing their portions of the bill on Monday. McConnell had planned to…

Read More

Georgia Bio Sign-on to State Medical Technology Alliance HHS & CMS Letter

June 29, 2020

Georiga Bio sign-on to the State Medical Technology Alliance (SMTA) letter to U.S. Department of Health and Human Services (HHS) and Centers for Medicare & Medicaid. Please see the language below. The Honorable Alex M. Azar IISecretaryU.S. Department of Health and Human Services200 Independence Avenue, S.W.Washington, D.C. 20201 The Honorable Seema VermaAdministratorCenters for Medicare &…

Read More

AdvaMed and Georgia Bio Send Letter to Natural Resources & Environment Committee Related to Ethylene Oxide

June 12, 2020

On behalf of the Advanced Medical Technology Association (AdvaMed) and Georgia Bio, we wrote to the Natural Resources & Environment Committee to share our comments on Senate Bill 426, being considered by the legislature, related to ethylene oxide. As you may know, billions of medical devices each year in the U.S. are sterilized using ethylene…

Read More

Advocating in the Age of COVID: Best Practices

May 26, 2020

By: Cornerstone Government Affairs As you manage how meetings have changed in the age of COVID-19, consider these best practices as you connect with policymakers in the age of COVID-19: Before the Meeting Email materials that you will use during the meeting, such as one-pagers, one day in advance. Make sure you have the materials…

Read More

USDA Implements Immediate Measures to Help Rural Residents, Businesses and Communities Affected by COVID-19

March 26, 2020

USDA Rural Development has taken a number of immediate actions to help rural residents, businesses and communities affected by the COVID-19 outbreak. Rural Development will keep our customers, partners, and stakeholders continuously updated as more actions are taken to better serve rural America. Read the full announcement to learn more about the opportunities USDA Rural Development is implementing…

Read More

COVID-19 SBA LOAN PROGRAMS

March 26, 2020

The following is a summary from our lobbying firm Cornerstone Government Affairs of the two small business loan programs created as a result of the COVID-19 Pandemic. The first program was created through the passage of what we are calling the “COVID-I” legislation. That bill created a $1 billion fund to immediately assist small businesses…

Read More

Georgia Bio Signs-on Multi-Association Letter on Buy American Executive Order

March 25, 2020

Today Georgia Bio joins several other associations to sign-on the U.S. Chamber Letter to Secretary Mnuchin, Secretary Ross, Ambassador Lighthizer, and Director Kudlow. The letter respectfully ask that the Trump administration defer moves to expand the reach of “Buy American” mandates to the medical equipment and biopharmaceutical sector during the present national emergency. Please see…

Read More

COVID-19 March 24, 2020 Federal Update

March 25, 2020

Legislation Supplemental III – “COVID-III” The hope continues to be that a deal can come together, that a time agreement can be reached, and that the Senate can vote expeditiously – if not yesterday night, then certainly by today. Absent any deal, the Senate would vote on cloture on the motion to proceed to the…

Read More

Georgia Bio Sends Governor Kemp Shelter in Place Exemption Language

March 24, 2020

On behalf of Georgia Bio and our members we asked Governor Kemp to consider shelter in place orders to prevent the spread of COVID-19 in Georgia to allow biopharmaceutical and medical device and diagnostics companies and distributors to operate so that prescription drugs and medical supplies remain accessible to those who need them. To effectuate…

Read More